ACHC:NSD-Acadia Healthcare Company Inc (USD)

COMMON STOCK | Medical Care Facilities | NSD

Last Closing Price

USD 56.12

Change

+0.18 (+0.32)%

Market Cap

USD 5.03B

Volume

0.56M

Avg Analyst Target

USD 71.83 (+28.00%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides education and children's, and adult care services. As of March 31, 2021, it operated a network of 228 behavioral healthcare facilities with approximately 10,000 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee. Address: 6100 Tower Circle, Franklin, TN, United States, 37067

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-10-27 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
AMED Amedisys Inc

-4.95 (-2.93%)

USD5.51B 22.69 14.96
LHCG LHC Group Inc

-1.23 (-0.90%)

USD4.31B 36.51 19.39
ENSG The Ensign Group Inc

-1.07 (-1.52%)

USD3.88B 21.12 16.67
SGRY Surgery Partners Inc

-0.96 (-2.34%)

USD3.38B 63.00 18.67
AMEH Apollo Medical Holdings Inc

-2.42 (-3.39%)

USD3.17B 55.87 15.87
PRSC The Providence Service Corpora..

N/A

USD2.21B 74.23 15.08
CMPS COMPASS Pathways plc

+1.21 (+3.16%)

USD1.63B N/A N/A
HCSG Healthcare Services Group Inc

-1.14 (-5.69%)

USD1.49B 21.12 14.04
ADUS Addus HomeCare Corporation

+1.56 (+1.90%)

USD1.31B 34.45 20.94
AVAH Aveanna Healthcare Holdings In..

+0.25 (+3.57%)

USD1.29B N/A 11.46

ETFs Containing ACHC

Symbol Name Weight Mer Price(Change) Market Cap
CHEP AGFiQ U.S. Market Neutral.. 0.00 % 1.42 %

N/A

USD0.75M
2B77:XETRA iShares IV Public Limited.. 0.00 % 0.40 %

-0.06 (-0.84%)

USD0.98B

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.66% 62% D- 58% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.66% 62% D- 57% F
Trailing 12 Months  
Capital Gain 93.72% 81% B- 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 93.72% 81% B- 83% B
Trailing 5 Years  
Capital Gain 52.33% 23% F 54% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 52.33% 23% F 50% F
Average Annual (5 Year Horizon)  
Capital Gain 18.08% 43% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.08% 43% F 63% D
Risk Return Profile  
Volatility (Standard Deviation) 62.41% 57% F 28% F
Risk Adjusted Return 28.97% 48% F 43% F
Market Capitalization 5.03B 96% A 85% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 47.80 38% F 21% F
Price/Book Ratio 2.20 78% C+ 56% F
Price / Cash Flow Ratio 7.63 52% F 42% F
EV/EBITDA 15.04 61% D- 48% F
Management Effectiveness  
Return on Equity 6.68% 55% F 61% D-
Return on Invested Capital 5.47% 48% F 67% D+
Return on Assets 4.31% 57% F 76% C
Debt to Equity Ratio 156.31% 21% F 13% F
Technical Ratios  
Short Ratio 6.08 30% F 23% F
Short Percent 4.25% 43% F 39% F
Beta 1.53 30% F 27% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Underpriced compared to book value

The stock is trading low compared to its peers on a price to book value basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector